openPR Logo
Press release

Orphan Drugs Market Growing CAGR of 11.6% with Renowned Players as Hoffmann- La Roche, Celgene Corporation, Alexion Pharmaceuticals and more. – Outlet Till 2023

08-02-2018 02:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Orphan Drugs Market

Orphan Drugs Market

Global Hepatitis C Drugs Market Information, By Drug Class Anti-Viral, Immuno-modulators and others, By Medicine System Allopathic, Alternative and Others, By Route of Administration and By End User - Forecast Till 2022

Global Orphan Drugs Market - Overview

The orphan drugs market is developing exponentially owing to the growing investment in research and development and unmet needs for rare diseases are the key factor driving the orphan drugs Market. The global market for orphan drugs is expected grow at a CAGR of 11.6% over the forecasted period.

Get Prime Sample Report @ https://www.marketresearchfuture.com/sample_request/2312

Currently, these orphan drugs are representing 35% of the total new drug approvals in the industry. The orphan drugs are disorders that affects a small percentage of the population. A pharmaceutical product aimed at rare diseases or disorders is known as an orphan drug. The major driving factor for the growth are extensive exclusivity, low marketing cost, legislative and tax benefits, government support leading to economic, and new technology development such as DNA recombinant, gene mapping, and hybridoma.

The limitation of distribution and commercialization channels are due to the differential availability of the product in the developed and developing countries due to social and economic factors.

Global Orphan Drugs Market - Key Players

Celgene Corporation (U.S.), F. Hoffmann- La Roche AG (Switerzland), Alexion Pharmaceuticals, Inc. (U.S.), Bayer AG (Germany), Takeda Pharmaceuticals Company Limited (Switerzland), Biogen Idec Limited (U.S.), Eli Lilly and Company (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Switerzland), Vertex pharmaceuticals, Inc. (U.S.), Sanofi (France), Johnson & Johnson (U.S.), Aegerion Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), GlaxoSmithKline plc (U.S.), Merck & Co., Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), AstraZeneca plc (UK), and others are some of the prominent players at the forefront of competition in the global orphan drugs market and are profiled in MRFR Analysis. 

Global Orphan Drugs Market - Company Analysis

This market is highly fragmented and is dominated by five major vendors including F. Hoffmann La Roche AG, Celgene Corporation, Bristol-Mayer Squibb Company, Novartis AG, and Pfizer Inc. as these are supposed to have extensive product portfolios. Factors such as the stringent rules and regulations, patent expiry of branded drugs, decreased R&D productivity, and high regulatory barriers are some significant challenges to the vendors during the forecast period.

Global Orphan Drugs Market - Industry Updates

Jan, 2017 Acucela Inc. received orphan drug FDA approval for emixustat for treatment of Stargardt disease. This approval is anticpated to be essential for the treatment of this genetic disease.

Nov, 2015 Ocata Therapeutics was acquired by Astellas Pharma to expand its product portfolio for treatment of retinal disorders such as age-related macular degeneration and Stargardt disease

June, 2015 Johns Hopkins University and Bayer Healthcare agreed to sign a five year collaboration agreement for developing treatment for diabetic macular edema, retinal vein occlusion, Stargardt's disease, geographic atrophy, and age-related macular degeneration

Get Your Customized Report @ https://www.marketresearchfuture.com/reports/orphan-drugs-market-2312

Global Orphan Drugs Market - Regional Analysis

The global orphan drugs market is segmented into four major regions including Americas, Europe, Asia Pacific, and Middle East and Africa region.

Globally, the Americas region is considered to be the largest market for orphan drugs. Factors such as the increasing government incentives, and high product demand are expected to promote market growth in the US region, which is reflected to be the highest revenue-generating region in the Americas.

The European regions is the second-largest market for Global orphan drugs. The upcoming market for orphan drugs is predicted to be subjugated by the developed regions with developing regions acting as a support pillar for its growth.

Asia Pacific will be the fastest growing regional market and is likely to be the key to the future. Middle East & Africa is expected to have limited but steady growth in the market.

Major Table of Content:

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Orphan Drugs Market, By Application

6 Global Orphan Drugs Market, By Pharmacological Class

7 Global Orphan Drugs Market, By Technology

8 Global Orphan Drugs Market, By Source

9 Global Orphan Drugs Market, By Regions

10 Company Landscape

11 Company Profile

12 Appendix              

TOC Continued……

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2312

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orphan Drugs Market Growing CAGR of 11.6% with Renowned Players as Hoffmann- La Roche, Celgene Corporation, Alexion Pharmaceuticals and more. – Outlet Till 2023 here

News-ID: 1159567 • Views:

More Releases from Market Research Future

Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6,585.15 Million by 2035 at 4% CAGR
Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6 …
The subsea manifolds market plays a critical role in modern offshore oil and gas production by enabling efficient control, distribution, and monitoring of hydrocarbons on the seabed. Subsea manifolds act as gathering points that connect multiple wells to production systems, allowing operators to optimize flow management, reduce infrastructure complexity, and improve overall field performance. As offshore exploration moves into deeper waters and more technically challenging environments, subsea manifolds have become
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
In an era defined by rapidly evolving cyber threats and digital warfare, the Military Cybersecurity industry is undergoing a fundamental transformation. As nation-states, defense organizations, and allied forces expand their reliance on digital networks, unmanned systems, IoT-enabled platforms, and cloud infrastructures, securing military cyberspace has become a strategic priority. The shifting threat landscape is driving unprecedented demand for advanced cybersecurity solutions that can protect critical defense assets, ensure operational continuity,
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Billion- 2035 | Trend, Demand, Regional Analysis
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase